Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Sigrid Therapeutics logo — 100% Natural Stability For Your Blood Sugar Levels and Weigh...

Sigrid Therapeutics

100% Natural Stability For Your Blood Sugar Levels and Weight

Founded 2014 Sweden Sweden 17 employees Total: $32.52M Biotechnology, Medical Devices

General Information

Company Name Sigrid Therapeutics
Founded Year 2014
Location Sweden Sweden
Employees 17
Industries Biotechnology, Medical Devices
Business Model D2C, B2B, B2B2C
Revenue Model Product Sales, Subscription
Social

BounceWatch is an independent company data service, not affiliated with Sigrid Therapeutics. To contact Sigrid Therapeutics, visit sigridthx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sigrid Therapeutics compare?

A PDF of Sigrid Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sigrid Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sigrid Therapeutics

Sigrid Therapeutics, founded in 2014, is a promising player in the Biotechnology and Medical Devices industries. Based in Sweden, the company aims to revolutionize personal health management with its slogan, "100% Natural Stability For Your Blood Sugar Levels and Weight".

Their unique value proposition lies in offering science-backed, 100% natural solutions designed to optimize metabolism. This approach enables consumers to maintain balanced and healthier lifestyles, making well-being an attainable goal for everyday life.

Recently, Sigrid Therapeutics secured a $4.00M Late VC investment on 01 October 2023, indicating strong investor confidence in its growth trajectory and market potential. This latest infusion of capital is likely to support the company's ongoing R&D and product development efforts, further solidifying their position in the health and wellness sector.

Business keywords: natural solutions, blood sugar management, prediabetes, healthtech, medical device, biotech, life science, metabolism optimization, obesity management, health innovation, ingested medical device, chronic disease management, preventive healthcare

Services & Products

Development of non-pharmaceutical solutions for metabolic health
Offering clinically validated metabolic health products
Implementation of patented SiPore technology across various industries

Target Customers

Individuals with prediabetes or diabetes Consumers seeking weight management solutions Healthcare providers Oral care product developers Pet nutrition and health companies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC $4.00M -
01 Oct 2023
Angel $1.02M -
01 Jan 2023
Seed $8.40M 2
Joyance Partners Irrus Investments
Joyance Partners, Irrus Investments
01 Nov 2021
Seed $1.60M 2
Joyance Partners
Joyance Partners, Bioarctic
01 Sep 2019
Round Undisclosed -
01 Jan 2015
Spinout $17.50M 1
NVEST VENTURE
NVEST VENTURE
01 Jan 2014

Sigrid Therapeutics Alternatives & Competitors

View All Alternatives
Sigrid Therapeutics vs
ReShape Lifesciences Inc.
ReShape Lifesciences Inc. United States

America’s premier weight-loss and metabolic health-solutions company.

Post-IPO Equity
38 employees
Biotechnology, Health Care
Sigrid Therapeutics vs
Intuity Medical, Inc.
Intuity Medical, Inc. United States

Making life with diabetes easier

Debt Financing
65 employees
Biotechnology, Health Care
Sigrid Therapeutics vs
dianosic
dianosic France

"Smartly designed for you"

Seed
13 employees
Biotechnology, Medical Devices
View all alternatives

FAQ About Sigrid Therapeutics

100% Natural Stability For Your Blood Sugar Levels and Weight
Sigrid Therapeutics was founded in 2014.
Sigrid Therapeutics is headquartered in Sweden.
Sigrid Therapeutics operates in Biotechnology and Medical Devices. Its work centres on natural solutions, blood sugar management, prediabetes and healthtech. Its customers include Individuals with prediabetes or diabetes, Consumers seeking weight management solutions and Healthcare providers.
Sigrid Therapeutics has a D2C, B2B and B2B2C business model. Its revenue comes from Product Sales and Subscription.
Sigrid Therapeutics has approximately 17 employees.
Sigrid Therapeutics has completed 6 funding rounds, raising a total of $32.52M.
Sigrid Therapeutics offers: Development of non-pharmaceutical solutions for metabolic health, Offering clinically validated metabolic health products, Implementation of patented SiPore technology across various industries.
Top alternatives and competitors to Sigrid Therapeutics include ReShape Lifesciences Inc., Intuity Medical, Inc., dianosic, CardiacSense, Intarcia Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sigrid Therapeutics and ReShape Lifesciences Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sigrid Therapeutics, https://bouncewatch.com/company/sigrid-therapeutics, updated 13 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout